Theriva Biologics's total assets for Q4 2024 were $35.35M, a decrease of -11.86% from the previous quarter. TOVX total liabilities were $16.29M for the fiscal quarter, a 5.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.